BICYCLE THERAPEUTICS plc
For the period ended Dec 31, 2023. Filed Feb 20, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Feb 20, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information
Insider Trading Arrangements
During our last fiscal quarter, our directors and officers (as defined in Rule 16a-1(f) under the Exchange Act)adopted or terminated the contracts, instructions or written plans for the purchase or sale of our securities set forth in the table below.
| | | | | | | |
|---|---|---|---|---|---|---|
| · · · Type of Trading Arrangement · · | ||||||
| Name and Position | Action | Adoption/Termination Date | Rule 10b5-1* | Non-Rule 10b5-1** | Total Shares of Ordinary Shares to be Sold | Expiration Date |
| Pierre Legault, Chairman | Adoption | October 11, 2023 | X | | 266,014 | October 12, 2026 |
- Contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.
** “Non-Rule 10b5-1 trading arrangement” as defined in Item 408(c) of Regulation S-K under the Exchange Act.
We adopted insider trading policies and procedures governing the purchase, sale, and/or other dispositions of our ordinary shares by directors, officers, employees and consultants that are reasonably designed to promote compliance with insider trading laws, rules and regulations, and the Nasdaq listing standards.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.